Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Nautilus Biotechnology, a pioneer in single-molecule protein analysis, will participate in the Morgan Stanley Global Healthcare Conference on September 12, 2022, at 11:05 a.m. ET. The event will feature a fireside chat with company management, and interested parties can access the live and archived webcast via the Investors section of Nautilus’ website.

Based in Seattle, Nautilus aims to transform proteomics by democratizing access to the proteome, facilitating advancements in human health and medicine.

News Market Reaction – NAUT

+0.46%

+0.46% Session move

In the trading session that priced this news, NAUT gained 0.46%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

Nautilus’ management is scheduled to participate in a fireside chat on Monday, September 12th at 11:05 a.m. Eastern Time / 8:05 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio. 

Investor Contact
investorrelations@nautilus.bio

Media Contact
press@nautilus.bio

 

FAQ

What event will Nautilus Biotechnology participate in?

Nautilus Biotechnology will participate in the Morgan Stanley Global Healthcare Conference on September 12, 2022.

When is Nautilus' presentation at the Morgan Stanley Conference?

Nautilus' fireside chat is scheduled for September 12, 2022, at 11:05 a.m. Eastern Time.

How can I access Nautilus Biotechnology's presentation?

The presentation can be accessed live and archived on the Investors section of Nautilus' website.

What is Nautilus Biotechnology focused on?

Nautilus focuses on developing a platform technology for quantifying and analyzing the proteome.

Where is Nautilus Biotechnology based?

Nautilus Biotechnology is based in Seattle, Washington.